BIVF (Boehringer Ingelheim Venture Fund)
Overview
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. More than 52,000 employees serve over 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. “To invest in the development of pioneering science – from idea to proof of concept – which offer the potential to provide significant benefits firstly for patients and also for our business.”
Reach BIVF (Boehringer Ingelheim Venture Fund) directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about BIVF (Boehringer Ingelheim Venture Fund)
What sectors does BIVF (Boehringer Ingelheim Venture Fund) invest in?
BIVF (Boehringer Ingelheim Venture Fund) invests in BioTech, Healthtech and Medical Devices, and is based in Ingelheim Am Rhein, Rheinland-Pfalz, Germany. BIVF (Boehringer Ingelheim Venture Fund) is listed as a corporate vc in the ConnectSafely investor database.
What stage does BIVF (Boehringer Ingelheim Venture Fund) invest at?
BIVF (Boehringer Ingelheim Venture Fund) backs companies at Seed, Growth and Series A.
Which regions does BIVF (Boehringer Ingelheim Venture Fund) invest in?
BIVF (Boehringer Ingelheim Venture Fund) invests across Agnostic (Global) and Germany.
Last updated · Source: ConnectSafely investor database
